Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease.
作者信息
Shen Chengli, Landsittel Douglas, Irazabal María V, Yu Alan S L, Chapman Arlene B, Mrug Michal, Grantham Jared J, Bae Kyongtae T, Bennett William M, Flessner Michael F, Torres Vicente E
机构信息
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Mayo Clinic College of Medicine, Rochester, Minnesota.
出版信息
Am J Kidney Dis. 2017 Mar;69(3):482-484. doi: 10.1053/j.ajkd.2016.10.021. Epub 2016 Dec 24.
Abstract
摘要
相似文献
1
Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease.在常染色体显性多囊肾病纵向研究中评估CKD-EPI方程估算肾小球滤过率的性能。
Am J Kidney Dis. 2017 Mar;69(3):482-484. doi: 10.1053/j.ajkd.2016.10.021. Epub 2016 Dec 24.
2
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.常染色体显性遗传多囊肾病患者肾功能下降的模式：HALT-PKD 试验的事后分析。
Am J Kidney Dis. 2018 May;71(5):666-676. doi: 10.1053/j.ajkd.2017.10.023. Epub 2018 Jan 3.
3
Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.常染色体显性多囊肾病中的肌酐管状分泌：对肾功能评估方程的横断面和纵向表现的影响。
Am J Kidney Dis. 2013 Sep;62(3):531-40. doi: 10.1053/j.ajkd.2013.03.030. Epub 2013 May 25.
4
Enzymatic creatinine assays allow estimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation.酶法肌酐检测可利用 CKD-EPI 方程在慢性肾脏病 1 期和 2 期估算肾小球滤过率。
Clin Chim Acta. 2014 Jan 20;428:89-95. doi: 10.1016/j.cca.2013.11.002. Epub 2013 Nov 10.
5
Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease.应用新 CKD-EPI 方程和其他方程估算常染色体显性多囊肾病患者的肾小球滤过率。
Am J Nephrol. 2010;31(1):53-7. doi: 10.1159/000256657. Epub 2009 Nov 4.
6
Performance of CKD-EPI equation to estimate glomerular filtration rate as compared to MDRD equation in South Brazilian individuals in each stage of renal function.CKD-EPI 方程与 MDRD 方程在评估肾功能各期南巴西个体肾小球滤过率的性能比较。
Clin Chem Lab Med. 2014 Dec;52(12):1747-54. doi: 10.1515/cclm-2014-0052.
7
Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease.托伐普坦对不同慢性肾脏病分期常染色体显性遗传性多囊肾病患者短期肾血流动力学的影响。
Kidney Int. 2013 Dec;84(6):1278-86. doi: 10.1038/ki.2013.285. Epub 2013 Jul 31.
8
[Evaluation and application of estimation of glomerular filtration rate based on serum creatinine and cystatin C in renal function staging].基于血清肌酐和胱抑素C的肾小球滤过率估算在肾功能分期中的评估与应用
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Nov 10;38(11):1557-1562. doi: 10.3760/cma.j.issn.0254-6450.2017.11.024.
9
Accuracy and precision of the CKD-EPI and MDRD predictive equations compared with glomerular filtration rate measured by inulin clearance in a Saudi population.在沙特人群中，将慢性肾脏病流行病学合作组（CKD-EPI）和肾脏病饮食改良试验（MDRD）预测方程的准确性和精密度与通过菊粉清除率测量的肾小球滤过率进行比较。
Ann Saudi Med. 2016 Mar-Apr;36(2):128-34. doi: 10.5144/0256-4947.2016.28.3.1715. Epub 2016 Mar 28.
10
A more accurate method acquirement by a comparison of the prediction equations for estimating glomerular filtration rate in Chinese patients with obstructive nephropathy.通过比较预测方程获取更准确的方法来估算中国梗阻性肾病患者的肾小球滤过率。
BMC Nephrol. 2016 Oct 18;17(1):150. doi: 10.1186/s12882-016-0345-0.
引用本文的文献
1
Development and validation of a new equation to estimate glomerular filtration rate in Argentinian adults.一种用于估算阿根廷成年人肾小球滤过率的新方程的开发与验证。
Sci Rep. 2025 Feb 20;15(1):6183. doi: 10.1038/s41598-025-90092-2.
2
Estimation of Glomerular Filtration Rate in Obese Patients: Utility of a New Equation.估算肥胖患者的肾小球滤过率：新方程的应用。
Nutrients. 2023 Feb 28;15(5):1233. doi: 10.3390/nu15051233.
3
A kidney resident macrophage subset is a candidate biomarker for renal cystic disease in preclinical models.肾脏固有巨噬细胞亚群是临床前模型中肾脏囊性疾病的候选生物标志物。
Dis Model Mech. 2023 Jan 1;16(1). doi: 10.1242/dmm.049810. Epub 2023 Jan 16.
4
A Systematic Review of Reported Outcomes in ADPKD Studies.常染色体显性多囊肾病（ADPKD）研究中报告结果的系统评价
Kidney Int Rep. 2022 Jul 5;7(9):1964-1979. doi: 10.1016/j.ekir.2022.06.012. eCollection 2022 Sep.
5
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International.托伐普坦治疗常染色体显性遗传性多囊肾病的应用进展：代表欧洲肾脏协会遗传性肾脏疾病工作组、欧洲罕见肾脏疾病参考网络和多囊肾病国际组织的共识声明。
Nephrol Dial Transplant. 2022 Apr 25;37(5):825-839. doi: 10.1093/ndt/gfab312.
6
Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan.常染色体显性多囊肾病中肾小球滤过率估计的最佳方程：托伐普坦的影响
Clin Exp Nephrol. 2018 Oct;22(5):1213-1223. doi: 10.1007/s10157-018-1574-2. Epub 2018 May 22.
本文引用的文献
1
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.常染色体显性多囊肾病（ADPKD）：来自改善全球肾脏病预后组织（KDIGO）争议会议的执行摘要
Kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59. Epub 2015 Mar 18.
2
GFR estimation: from physiology to public health.肾小球滤过率估计：从生理学到公共卫生。
Am J Kidney Dis. 2014 May;63(5):820-34. doi: 10.1053/j.ajkd.2013.12.006. Epub 2014 Jan 28.
3
Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.常染色体显性多囊肾病中的肌酐管状分泌：对肾功能评估方程的横断面和纵向表现的影响。
Am J Kidney Dis. 2013 Sep;62(3):531-40. doi: 10.1053/j.ajkd.2013.03.030. Epub 2013 May 25.
4
Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study.在 ADPKD 患者中测量和估计 GFR 及治疗效果：一项纵向队列研究的结果及意义。
PLoS One. 2012;7(2):e32533. doi: 10.1371/journal.pone.0032533. Epub 2012 Feb 28.
5
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病的肾脏体积和功能结局。
Clin J Am Soc Nephrol. 2012 Mar;7(3):479-86. doi: 10.2215/CJN.09500911. Epub 2012 Feb 16.
6
Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review.估算肌酐标准化时代肾小球滤过率的估算方程：系统评价。
Ann Intern Med. 2012 Jun 5;156(11):785-95. doi: 10.7326/0003-4819-156-11-201203200-00391. Epub 2012 Feb 6.
7
Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease.应用新 CKD-EPI 方程和其他方程估算常染色体显性多囊肾病患者的肾小球滤过率。
Am J Nephrol. 2010;31(1):53-7. doi: 10.1159/000256657. Epub 2009 Nov 4.
8
Volume progression in polycystic kidney disease.多囊肾病中的体积进展
N Engl J Med. 2006 May 18;354(20):2122-30. doi: 10.1056/NEJMoa054341.
9
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.早期常染色体显性多囊肾病肾功能下降测定方法的比较：多囊肾病队列放射影像学研究联盟
J Am Soc Nephrol. 2006 Mar;17(3):854-62. doi: 10.1681/ASN.2005070697. Epub 2006 Feb 1.
10
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.常染色体显性多囊肾病（ADPKD）早期的肾脏结构：多囊肾病放射影像学研究联盟（CRISP）队列
Kidney Int. 2003 Sep;64(3):1035-45. doi: 10.1046/j.1523-1755.2003.00185.x.
Zotero 插件